Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H11N3O |
Molecular Weight | 225.2459 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(=O)C1=NC=C2NC3=C(C=CC=C3)C2=C1
InChI
InChIKey=QMCOPDWHWYSJSA-UHFFFAOYSA-N
InChI=1S/C13H11N3O/c1-14-13(17)11-6-9-8-4-2-3-5-10(8)16-12(9)7-15-11/h2-7,16H,1H3,(H,14,17)
Molecular Formula | C13H11N3O |
Molecular Weight | 225.2459 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18078430Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27838748 | https://www.ncbi.nlm.nih.gov/pubmed/15655523
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18078430
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27838748 | https://www.ncbi.nlm.nih.gov/pubmed/15655523
FG-7142 is a partial inverse agonist at the benzodiazepine allosteric site with its highest affinity for the α1 subunit-containing GABAA receptor, although it is not selective. FG-7142 also has its highest efficacy for modulation of GABA-induced chloride flux mediated at the α1 subunit-containing GABAA receptor. FG-7142 activates a recognized anxiety-related neural network and interacts with serotonergic, dopaminergic, cholinergic, and noradrenergic modulatory systems within that network. FG-7142 has been shown to induce anxietyrelated behavioral and physiological responses in a variety of experimental paradigms across numerous mammalian and non-mammalian species, including humans. FG-7142 has proconflict actions across anxiety-related behavioral paradigms, modulates attentional processes, and increases cardioacceleratory sympathetic reactivity and neuroendocrine reactivity. Both acute and chronic FG-7142 treatment are proconvulsive, upregulate cortical adrenoreceptors, decrease subsequent actions of GABA and β-carboline agonists, and increase the effectiveness of subsequent GABAA receptor antagonists and β-carboline inverse agonists. FG-7142, as a partial inverse agonist, can help to elucidate individual components of full agonism of benzodiazepine binding sites and may serve to identify the specific GABAA receptor subtypes involved in specific behavioral and physiological responses.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18078430 |
265.0 nM [Ki] | ||
Target ID: CHEMBL2094121 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15655523 |
91.0 nM [Ki] | ||
Target ID: CHEMBL2094130 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15655523 |
330.0 nM [Ki] | ||
Target ID: CHEMBL2094120 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15655523 |
492.0 nM [Ki] | ||
Target ID: CHEMBL2094122 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15655523 |
2150.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Chlordiazepoxide enhances the anxiogenic action of CGS 8216 in the social interaction test: evidence for benzodiazepine withdrawal? | 1985 Jul |
|
Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites. | 1985 Oct 24 |
|
Behavioural and biochemical evidence for a long-lasting decrease in GABAergic function elicited by chronic administration of FG 7142. | 1986 Oct 1 |
|
Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine. | 2003 Aug 22 |
|
Tail-swing behavior: a novel animal model for anxiety. | 2003 Jun |
|
Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. | 2003 Mar 7 |
|
Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats. | 2005 May |
|
Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs. | 2006 Jan |
|
Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice? | 2006 Mar |
|
Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. | 2007 May 11 |
|
Effects of the interaction between beta-carboline-3-carboxylic acid N-methylamide and polynucleotides on singlet oxygen quantum yield and DNA oxidative damage. | 2007 Nov-Dec |
|
Early life programming of hemispheric lateralization and synchronization in the adult medial prefrontal cortex. | 2008 Aug 26 |
|
Early life stress causes FG-7142-induced corticolimbic dysfunction in adulthood. | 2008 Feb 8 |
|
A spectroscopic study of the interaction of the fluorescent beta-carboline-3-carboxylic acid N-methylamide with DNA constituents: nucleobases, nucleosides and nucleotides. | 2008 Sep |
|
The anxiogenic drug FG7142 increases self-injurious behavior in male rhesus monkeys (Macaca mulatta). | 2009 Nov 18 |
|
Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala. | 2010 Oct 1 |
|
Modulation of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) by 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives, ligands of peripheral benzodiazepine receptor (PBR). | 2011 Apr 25 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18078430
10–100 mg/kg i.p.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15655523
The affinity of FG 7142 (2nM-10mkM) for various human recombinant GABAA receptors (b3, g2 plus either a1, a2, a3, a4, a5 or a6 subunits) was measuredin mouse fibroblast L(tk-) cells. Membrane preparations from cells expressing a1-, a2-, a3- or a5-containing GABAA receptors were incubatedwith 1.8 nM [ 3 H]Ro 15-1788, whereas the radioligand used for a4- or a6-containing receptors was 8.0 nM [3H]Ro 15-4513. Nonspecific binding (NSB) was defined using 10 mM (final concentration) flunitrazepam for the a1, a2, a3 and a5 subtypes and10 mM Ro 15-4513 for the a4 and a6 subtypes. IC50 values were calculatedusing XLfit (IDBS, Guildford, U.K.) and converted to KI values using the Cheng– Prussof equation (Cheng & Prussof, 1973) assuming respective affinities (KD values) for [3 H]Ro 15-1788 of 0.92, 1.05, 0.58 and 0.45 nM at a1-, a2-, a3- or a5-containing receptors and5.0 and 6.5 nM for [3 H]Ro 15-4513 at a4- and a6-containing receptors
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:50:55 GMT 2023
by
admin
on
Fri Dec 15 17:50:55 GMT 2023
|
Record UNII |
60PO70N1BP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID30999832
Created by
admin on Fri Dec 15 17:50:55 GMT 2023 , Edited by admin on Fri Dec 15 17:50:55 GMT 2023
|
PRIMARY | |||
|
78538-74-6
Created by
admin on Fri Dec 15 17:50:55 GMT 2023 , Edited by admin on Fri Dec 15 17:50:55 GMT 2023
|
PRIMARY | |||
|
60PO70N1BP
Created by
admin on Fri Dec 15 17:50:55 GMT 2023 , Edited by admin on Fri Dec 15 17:50:55 GMT 2023
|
PRIMARY | |||
|
FG-7142
Created by
admin on Fri Dec 15 17:50:55 GMT 2023 , Edited by admin on Fri Dec 15 17:50:55 GMT 2023
|
PRIMARY | |||
|
4375
Created by
admin on Fri Dec 15 17:50:55 GMT 2023 , Edited by admin on Fri Dec 15 17:50:55 GMT 2023
|
PRIMARY |